Dr Reddy's plans EU launch for biosimilar cancer treatmentZenopaDr Reddy's Laboratories is planning to launch a biosimilar version of Roche's non-Hodgkin's lymphoma treatment rituximab in Europe. The company is in talks with European re…
Now, wireless heart implant powered by radio waves – Times of India
Now, wireless heart implant powered by radio wavesTimes of IndiaThe Stanford researchers demonstrated wireless power transfer to a millimeter-sized device implanted five centimeters inside the chest on the surface of the heart, a depth once thought out…
Cramlington heart transplant girl scoops medals at Transplant Games
JUST six months ago, Rachel Hooley was lying in a hospital bed waiting for a lifesaving heart transplant.
N.C. Eye Bank helps restore sight to people around the world – Winston-Salem Journal
N.C. Eye Bank helps restore sight to people around the worldWinston-Salem JournalThe North Carolina Eye Bank's Dee Hatcher uses a magnified image on a computer screen to count cells in a thin sliver of human eye tissue to help determine its health …
Taylor lauds Kiwi team effort – sportal.co.in
Sport LIVETaylor lauds Kiwi team effortsportal.co.inNew Zealand skipper Ross Taylor lamented losing the second Test to India but took heart in the team's improvement through the two-Test series. An unbeaten 96-run stand between Virat Kohli and Mahe…
Children taking steroids for asthma are slightly shorter than peers – Phys.Org
Sun News NetworkChildren taking steroids for asthma are slightly shorter than peersPhys.OrgAll children received albuterol, a fast-acting drug for relief of acute asthma symptoms, and oral corticosteroids as needed for asthma symptoms. The researchers …
Pharmaceutical sector roundup: UR Associates – Moneycontrol.com
Pharmaceutical sector roundup: UR AssociatesMoneycontrol.comThe original form of the drug is called Rituximab, and is sold by its innovator Roche AG. Reddy's effort to launch the world's first MAb “biosimilar” is expected to happen jointly …
StemCells Announces Positive Interim Data From Spinal Cord Injury Trial
StemCells Announces Positive Interim Data From Spinal Cord Injury Trial
Cramlington heart transplant girl scoops medals at British Transplant Games
JUST six months ago, Rachel Hooley was lying in a hospital bed waiting for a lifesaving heart transplant.
StemCells, Inc. Reports Positive Interim Data From Spinal Cord Injury Trial
NEWARK, Calif. — StemCells, Inc. today announced that interim six-month data from the first patient cohort in the Company's Phase I/II clinical trial of its proprietary HuCNS-SC(R) product candidate (purified …